13.8 %About 13.8% of Zika virus-neutralizing antibodies did not cross-react with dengue, yellow fever, and West Nile viruses.
Nigeriadengue · fièvre jaune · West Nile viruspublished 2023PloS onePubMeddocument of 10 observations
Gold tier: mechanically validated evidence, with its primary source.
4 evidence items · page 1 / 1
13.8 %About 13.8% of Zika virus-neutralizing antibodies did not cross-react with dengue, yellow fever, and West Nile viruses.
Nigeriadengue · fièvre jaune · West Nile viruspublished 2023PloS onePubMeddocument of 10 observations
1 %Yellow fever recorded a coefficient of determination (R²) of 0.01, indicating that 1% of the variance in confirmed yellow fever diagnoses was explained by the studied risk factors.
Nigeriafièvre jauneobserved 2021published 2026BMC infectious diseasesPubMeddocument of 17 observations
7.1 %7.1% of the sera with Zika virus neutralizing antibodies also neutralized yellow fever virus.
Nigeriafièvre jaunepublished 2023PloS onePubMeddocument of 10 observations
39.1 %The most common febrile illness reported was yellow fever, cited by 39.1% of respondents.
Nigeriafièvre jaunepublished 2003Journal of ethnopharmacologyeurope_pmcdocument of 15 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.